1. Home
  2. NSSC vs PGEN Comparison

NSSC vs PGEN Comparison

Compare NSSC & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.16

Market Cap

1.6B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.83

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
PGEN
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
NSSC
PGEN
Price
$37.16
$4.83
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$48.17
$8.33
AVG Volume (30 Days)
379.4K
4.9M
Earning Date
05-04-2026
05-13-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$181,621,000.00
$230,981,000.00
Revenue This Year
$13.63
$1,115.92
Revenue Next Year
$10.05
$81.04
P/E Ratio
$53.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.44
$1.40
52 Week High
$47.61
$5.47

Technical Indicators

Market Signals
Indicator
NSSC
PGEN
Relative Strength Index (RSI) 48.52 64.17
Support Level $34.77 $3.96
Resistance Level $38.07 $5.06
Average True Range (ATR) 1.15 0.29
MACD 0.45 0.10
Stochastic Oscillator 69.91 97.39

Price Performance

Historical Comparison
NSSC
PGEN

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: